CN113117004A - 一种治疗股骨头坏死的中药配方 - Google Patents

一种治疗股骨头坏死的中药配方 Download PDF

Info

Publication number
CN113117004A
CN113117004A CN202110415617.XA CN202110415617A CN113117004A CN 113117004 A CN113117004 A CN 113117004A CN 202110415617 A CN202110415617 A CN 202110415617A CN 113117004 A CN113117004 A CN 113117004A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
femoral head
medicine formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202110415617.XA
Other languages
English (en)
Inventor
张庆达
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN202110415617.XA priority Critical patent/CN113117004A/zh
Publication of CN113117004A publication Critical patent/CN113117004A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A61K36/258—Panax (ginseng)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A61K35/586—Turtles; Tortoises, e.g. terrapins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/11—Pteridophyta or Filicophyta (ferns)
    • A61K36/12—Filicopsida or Pteridopsida
    • A61K36/126—Drynaria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明涉及中药配方技术领域，尤其涉及一种治疗股骨头坏死的中药配方。该一种治疗股骨头坏死的中药配方包括如下重量份：西洋参5‑10份；三七5‑10份；龟胶10‑15份；穿山甲3‑7份；海马3‑7份；血竭5‑10份；份白芷10份；肉桂3份；骨碎补10份；透骨草10份。本发明提供的一种治疗股骨头坏死的中药配方，通过而挥发油提高了治疗效果，各组分药物协同作用，相辅相成，活血理气、散寒除湿、温通经脉、强筋壮骨、补肝益肾、生新止痛，益气血对股骨头无菌性缺血性坏死有较好疗效。

Description

一种治疗股骨头坏死的中药配方
技术领域
本发明涉及中药配方技术领域，尤其涉及一种治疗股骨头坏死的中药配方。
背景技术
股骨头坏死是世界骨科公认的疑难病，它严重危害人类的健康，轻则使人致残，重则使人瘫痪，丧失劳动和生活自理能力。普遍认为股骨头坏死的病因主要有：外伤、激素、酗酒或骨质疏松等。主要临床症状是疼痛和髋关节活动功能障碍。对于此病，前期主要采取保守疗法，晚期则采用人工置换术。目前虽有多种治疗股骨头坏死的药物出现，但不同程度存在着组方繁杂、成本高、疗程长、副作用大、疗效不理想等缺点。
发明内容
针对现有技术的上述缺陷，本发明提供的一种治疗股骨头坏死的中药配方，解决了上述技术问题，提供一种能够有效治疗的股骨头坏死的中药配方。
为了达到上述目的，本发明提供如下技术方案：
一种治疗股骨头坏死的中药配方包括如下重量份：西洋参5-10份；三七5-10份；龟胶10-15份；穿山甲3-7份；海马3-7份；血竭5-10份。
其中，一种治疗股骨头坏死的中药配方，包括如下重量份：西洋参5份；三七5份；龟胶15份；穿山甲3份；海马3份；血竭10份。
其中，一种治疗股骨头坏死的中药配方，包括如下重量份：西洋参10份；三七10份；龟胶15份；穿山甲3份；海马7份；血竭10份。
其中，一种治疗股骨头坏死的中药配方，包括如下重量份：西洋参8份；三七7份；龟胶12份；穿山甲5份；海马4份；血竭7份。
其中，一种治疗股骨头坏死的中药配方还包括如下重量份：骨碎补5-10份；肿节风5-10份；木豆叶10-15份。
其中，一种治疗股骨头坏死的中药配方还包括如下重量份：骨碎补7份；肿节风8份；木豆叶12。
一种治疗股骨头坏死的中药配方包括如下制备方法：
步骤一将骨碎补、肿节风和木豆叶加水适量制成挥发油；
步骤二将西洋参、三七、龟胶、穿山甲、海马和血竭分别加热适量水制成挥发油；
步骤三采用饱和水溶液法，用β-环糊精进行包合，β-环糊精与水的质量体积比为1∶4。
本发明的有益效果是：本发明提供的一种治疗股骨头坏死的中药配方，通过而挥发油提高了治疗效果，各组分药物协同作用，相辅相成，活血理气、散寒除湿、温通经脉、强筋壮骨、补肝益肾、生新止痛，益气血对股骨头无菌性缺血性坏死有较好疗效。
为了能更进一步了解本发明的特征以及技术内容，请参阅以下有关本发明的详细说明。
具体实施方式
为更进一步阐述本发明所采取的技术手段及其效果，以下结合本发明的优选实施例进行详细描述。
一种治疗股骨头坏死的中药配方包括如下重量份：西洋参5-10份；三七5-10份；龟胶10-15份；穿山甲3-7份；海马3-7份；血竭5-10份。
一种治疗股骨头坏死的中药配方还包括如下重量份：骨碎补5-10份；肿节风5-10份；木豆叶10-15份。
实施例1：一种治疗股骨头坏死的中药配方，包括如下重量份：西洋参5份；三七5份；龟胶15份；穿山甲3份；海马3份；血竭10份。
一种治疗股骨头坏死的中药配方还包括如下重量份：骨碎补5份；肿节风10份；木豆叶12份。
实施例2：一种治疗股骨头坏死的中药配方，包括如下重量份：西洋参10份；三七10份；龟胶15份；穿山甲3份；海马7份；血竭10份。
一种治疗股骨头坏死的中药配方还包括如下重量份：骨碎补7份；肿节风8份；木豆叶12。
实施例3：一种治疗股骨头坏死的中药配方，包括如下重量份：西洋参8份；三七7份；龟胶12份；穿山甲5份；海马4份；血竭7份。
一种治疗股骨头坏死的中药配方还包括如下重量份：骨碎补8份；肿节风9份；木豆叶11份。
一种治疗股骨头坏死的中药配方包括如下制备方法：
步骤一将骨碎补、肿节风和木豆叶加水适量制成挥发油；
步骤二将西洋参、三七、龟胶、穿山甲、海马和血竭分别加热适量水制成挥发油；
步骤三采用饱和水溶液法，用β-环糊精进行包合，β-环糊精与水的质量体积比为1∶4。
以上所述，仅为本发明的具体实施方式，但本发明的保护范围并不局限于此，任何熟悉本技术领域的技术人员在本发明揭露的技术范围内，可轻易想到变化或替换，都应涵盖在本发明的保护范围之内。因此，本发明的保护范围应所述以权利要求的保护范围为准。

Claims (7)

1.一种治疗股骨头坏死的中药配方，其特征在于，包括如下重量份：西洋参5-10份；三七5-10份；龟胶10-15份；穿山甲3-7份；海马3-7份；血竭5-10份。
2.根据权利要求1所述的一种治疗股骨头坏死的中药配方，其特征在于，包括如下重量份：西洋参5份；三七5份；龟胶15份；穿山甲3份；海马3份；血竭10份。
3.根据权利要求1所述的一种治疗股骨头坏死的中药配方，其特征在于，包括如下重量份：西洋参10份；三七10份；龟胶15份；穿山甲3份；海马7份；血竭10份。
4.根据权利要求1所述的一种治疗股骨头坏死的中药配方，其特征在于，包括如下重量份：西洋参8份；三七7份；龟胶12份；穿山甲5份；海马4份；血竭7份。
5.根据权利要求1所述的一种治疗股骨头坏死的中药配方，其特征在于，还包括如下重量份：骨碎补5-10份；肿节风5-10份；木豆叶10-15份。
6.根据权利要求5所述的一种治疗股骨头坏死的中药配方，其特征在于，包括如下重量份：骨碎补7份；肿节风8份；木豆叶12。
7.根据权利要求5所述的一种治疗股骨头坏死的中药配方，其特征在于，包括如下制备方法：
步骤一将骨碎补、肿节风和木豆叶加水适量制成挥发油；
步骤二将西洋参、三七、龟胶、穿山甲、海马和血竭分别加热适量水制成挥发油；
步骤三采用饱和水溶液法，用β-环糊精进行包合，β-环糊精与水的质量体积比为1∶4。
CN202110415617.XA 2021-04-16 2021-04-16 一种治疗股骨头坏死的中药配方 Pending CN113117004A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110415617.XA CN113117004A (zh) 2021-04-16 2021-04-16 一种治疗股骨头坏死的中药配方

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110415617.XA CN113117004A (zh) 2021-04-16 2021-04-16 一种治疗股骨头坏死的中药配方

Publications (1)

Publication Number Publication Date
CN113117004A true CN113117004A (zh) 2021-07-16

Family

ID=76777344

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110415617.XA Pending CN113117004A (zh) 2021-04-16 2021-04-16 一种治疗股骨头坏死的中药配方

Country Status (1)

Country Link
CN (1) CN113117004A (zh)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1389252A (zh) * 2002-07-24 2003-01-08 李如元 一种治疗股骨头坏死的药物组合物
CN1817366A (zh) * 2005-11-04 2006-08-16 纪冠军 一种治疗风湿骨病的药物组合物及其制备方法
CN107469020A (zh) * 2017-10-10 2017-12-15 王辉 一种治疗股骨头坏死以及颈肩腰腿疼痛的膏药贴
CN108653668A (zh) * 2018-06-21 2018-10-16 茌东波 治疗股骨头坏死、各种骨科疾病的膏药配方以及制作方法
CN109876084A (zh) * 2019-02-11 2019-06-14 唐弢 一种治疗股骨头坏死的药物组合物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1389252A (zh) * 2002-07-24 2003-01-08 李如元 一种治疗股骨头坏死的药物组合物
CN1817366A (zh) * 2005-11-04 2006-08-16 纪冠军 一种治疗风湿骨病的药物组合物及其制备方法
CN107469020A (zh) * 2017-10-10 2017-12-15 王辉 一种治疗股骨头坏死以及颈肩腰腿疼痛的膏药贴
CN108653668A (zh) * 2018-06-21 2018-10-16 茌东波 治疗股骨头坏死、各种骨科疾病的膏药配方以及制作方法
CN109876084A (zh) * 2019-02-11 2019-06-14 唐弢 一种治疗股骨头坏死的药物组合物

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
梅全喜等: "《广东地产药材研究》", 31 May 2011, 广东科技出版社 *

Similar Documents

Publication Publication Date Title
CN104147577B (zh) 一种用于促进骨痂生长治疗骨折的膏药
CN102920876B (zh) 一种治疗膝关节骨性关节炎的外敷中药组合物
CN103990079B (zh) 用于治疗气滞血瘀型腰肌劳损的药物组合物及其制备方法
CN102100754A (zh) 一种治疗骨质增生的中药组合物
CN101607015A (zh) 一种治疗股骨头缺血性坏死的中药组合物
CN101357168B (zh) 一种治疗风湿性关节炎的药酒
CN102579634B (zh) 治疗膝关节骨性关节炎的外用中药组合物
CN1339313A (zh) 舒筋活血纯中药制剂
CN113117004A (zh) 一种治疗股骨头坏死的中药配方
CN104161890B (zh) 一种治疗骨质增生的中药颗粒
CN103751427B (zh) 一种治疗桡骨远端骨折的瑶药
CN102697883B (zh) 一种治疗骨关节炎的膏药
CN101991672A (zh) 一种治疗椎间盘突出和骨质增生的药酒及其制备方法
CN103536712A (zh) 一种治疗股骨头坏死的中药制剂
CN104800443B (zh) 一种补肾生髓续骨剂
CN107551229A (zh) 一种药物组合物及其制备方法和用途
CN105816755A (zh) 一种治疗腰椎、颈椎风湿骨病的乌龙通痹丸
CN102106940A (zh) 一种治疗坐骨神经痛的中药药酒
CN104225119A (zh) 腰疼散
CN107456517A (zh) 一种含有土鳖的治疗股骨头无菌性坏死症的中药
CN101953941B (zh) 一种治疗股骨头坏死的中药药酒
CN106421098B (zh) 治疗多种骨病的外用中药组合物
CN109939213A (zh) 纯阳通络止痛液
CN104383205A (zh) 一种治疗骨科病的舒筋活血外用药酒
CN104306526A (zh) 一种治疗臂丛神经炎的中药组合物

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20210716